Flagellate erythema induced by bleomycin toxicity
نویسندگان
چکیده
منابع مشابه
Bleomycin-induced flagellate erythema.
of bleomycin or its derivative peplomycin, occurs in 8-20% patients during systemic or local therapy (1). It characterised by a linear erythematous streak with hyperpigmentation (2, 3), and was first described by Moulin in 1970 (4). Herein, we present a typical case of flagellate erythema induced by Bleomycin. A 32 year-old Taiwanese male with mixed germ cell tumour of the anterior mediastinum ...
متن کاملBleomycin‐induced flagellate hyperpigmentation
A 27-year old male with Hodgkin's lymphoma was treated with combined chemotherapy that included bleomycin. He presented with pruritic erythematous, edematous linear lesions and was diagnosed to have flagellate hyperpigmentation, a rare side effect of bleomycin chemotherapy.
متن کاملBleomycin-induced flagellate dermatitis
A 29-year-old woman with stage IVB Hodgkin's lymphoma was treated with doxorubicin, bleomycin, vinblastine, and dacarbazine. Two weeks after the first cycle was completed, she developed pruritic, linear erythematous lesions in a flagellate-like pattern on the trunk, neck and arms. After oral prednisone therapy and cessation of bleomycin, the lesions started to recede.
متن کاملBleomycin-induced flagellate hyperpigmentation.
Bleomycin is a chemotherapeutic agent used in the treatment of different tumours. It has several side effects, including flagellate hyperpigmentation, which is a unique and a well-documented side effect of bleomycin therapy. We report a case of a 23-year-old woman with a personal history of ovarian dysgerminoma, who developed flagellate hyperpigmentation on trunk after bleomycin therapy.
متن کاملBleomycin-Induced Flagellate Dermatitis
Flagellate dermatitis is an uncommon cutaneous drug reaction with a characteristic whip-like appearance that occurs in the setting of bleomycin administration, an agent used in chemotherapy. Bleomycin toxicity is frequently dose-related and lesions typically disappear after discontinuation of the drug although residual hyperpigmentation can remain. Due to the number of patients undergoing treat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Medical and Paediatric Oncology
سال: 2013
ISSN: 0971-5851
DOI: 10.4103/0971-5851.125265